FRM
Fox Run Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.01M | Sell |
18,361
-4,748
| -21% | -$261K | 0.17% | 186 |
|
|
2025
Q1 | $1.63M | Buy |
23,109
+14,893
| +181% | +$1.05M | 0.25% | 62 |
|
|
2024
Q4 | $540K | Sell |
8,216
-6,150
| -43% | -$404K | 0.1% | 413 |
|
|
2024
Q3 | $1.01M | Buy |
14,366
+8,670
| +152% | +$609K | 0.22% | 121 |
|
|
2024
Q2 | $469K | Sell |
5,696
-4,254
| -43% | -$350K | 0.09% | 432 |
|
|
2024
Q1 | $869K | Sell |
9,950
-831
| -8% | -$72.6K | 0.19% | 176 |
|
|
2023
Q4 | $1.04M | Buy |
10,781
+5,780
| +116% | +$557K | 0.27% | 76 |
|
|
2023
Q3 | $442K | Sell |
5,001
-13,401
| -73% | -$1.19M | 0.13% | 303 |
|
|
2023
Q2 | $1.6M | Buy |
+18,402
| New | +$1.6M | 0.45% | 11 |
|
|
2022
Q3 | – | Sell |
-2,741
| Closed | -$227K | – | 612 |
|
|
2022
Q2 | $227K | Sell |
2,741
-8,603
| -76% | -$712K | 0.11% | 387 |
|
|
2022
Q1 | $875K | Buy |
11,344
+3,862
| +52% | +$298K | 0.49% | 17 |
|
|
2021
Q4 | $661K | Buy |
7,482
+4,321
| +137% | +$382K | 0.39% | 42 |
|
|
2021
Q3 | $244K | Buy |
+3,161
| New | +$244K | 0.15% | 303 |
|
|
2016
Q3 | – | Sell |
-10,600
| Closed | -$825K | – | 499 |
|
|
2016
Q2 | $825K | Buy |
10,600
+3,200
| +43% | +$249K | 0.4% | 23 |
|
|
2016
Q1 | $610K | Buy |
+7,400
| New | +$610K | 0.41% | 43 |
|